| Seroconversion rates following COVID-19 vaccination among patients with cancer A Thakkar, JD Gonzalez-Lugo, N Goradia, R Gali, LC Shapiro, K Pradhan, ... Cancer cell 39 (8), 1081-1090. e2, 2021 | 324 | 2021 |
| Risk of pulmonary emboli after removal of an upper extremity central catheter associated with a deep vein thrombosis DE Houghton, HH Billett, M Gaddh, O Onadeko, G George, TF Wang, ... Blood Advances 5 (14), 2807-2812, 2021 | 11 | 2021 |
| Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network US retrospective cohort study LB Kreuziger, M Gaddh, O Onadeko, G George, TF Wang, TH Oo, ... Thrombosis research 202, 155-161, 2021 | 10 | 2021 |
| Efficacy and safety of direct oral factor Xa inhibitors in patients after bariatric surgery M Kushnir, R Gali, M Alexander, HHH Billett Blood 134, 2439, 2019 | 10 | 2019 |
| High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccination LC Shapiro, A Thakkar, R Gali, JD Gonzalez-Lugo, AH Bazarbachi, ... Leukemia & Lymphoma 63 (10), 2484-2488, 2022 | 6 | 2022 |
| Seroconversion rates following COVID-19 vaccination amongst patients with malignant disease-the impact of diagnosis and cancer-directed therapies A Thakkar, JG Lugo, N Goradia, R Gali, LC Shapiro, K Pradhan, ... medRxiv, 2021.05. 07.21256824, 2021 | 4 | 2021 |
| Optimal timing for removal of an upper extremity central catheter when associated with a deep vein thrombosis: a venous thromboembolism network US multicenter retrospective … DE Houghton, HHH Billett, M Gaddh, O Onadeko, G George, TF Wang, ... Blood 134, 325, 2019 | 3 | 2019 |
| Wide variation in duration of anticoagulation after catheter-related thrombosis: a venous thromboembolism network US multicenter retrospective cohort study LB Kreuziger, M Gaddh, O Onadeko, G George, TF Wang, TH Oo, M Feng, ... Blood 132, 1248, 2018 | 3 | 2018 |
| High Seroconversion Rates Amongst Black and Hispanics With Hematologic Malignancies after SARS-CoV-2 Vaccination (preprint) LC Shapiro, A Thakkar, R Gali, JD Gonzalez-Lugo, AH Bazarbachi, ... | 2 | 2021 |
| Direct oral Xa inhibitors for the treatment of venous thromboembolism after bariatric surgery M Kushnir, R Gali, M Alexander, HH Billett Blood Advances 7 (2), 224-226, 2023 | 1 | 2023 |
| Seroconversion rates after COVID-19 vaccination amongst patients with hematologic malignancies: results of a rapid vaccination and evaluation program in a minority rich … LC Shapiro, R Gali, A Thakkar, JD Gonzalez-Lugo, AH Bazarbachi, ... Blood 138, 2537, 2021 | 1 | 2021 |
| COVID-19 infections among minority patients with gastrointestinal malignancies in urban safety net academic medical centers. R Gali, MA Viteri Malone, S Goel Journal of Clinical Oncology 40 (16_suppl), e15610-e15610, 2022 | | 2022 |
| Survival analysis of patients with early and standard onset colorectal cancer: A single center study. D Patel, C Martins Maia, M Lyudmer, S Tolu, A Chergui, RJ Patel, SY Kim, ... Journal of Clinical Oncology 40 (16_suppl), e15512-e15512, 2022 | | 2022 |
| Assessing Clinical Outcomes in Patients Undergoing Splenectomy for Immune Thrombocytopenia: A Real World Perspective E Rabinovich, K Pradhan, HT Davido, R Gali, I Islam, P Muscarella, ... Blood 138, 3161, 2021 | | 2021 |
| Expanding the Role of Checkpoint Inhibitors in Immune Cold Tumors A Acuna-Villaorduna, R Gali, A Chergui, S Goel Advances in Oncology 1, 85-95, 2021 | | 2021 |
| Late-Onset Cytokine Release Syndrome (CRS) in HIV Patient with Relapsed Classical Hodgkin Lymphoma on Nivolumab and Non-Compliance with Anti-Retroviral Therapy R Gali, D Alejos, I Mantzaris Blood 136, 17, 2020 | | 2020 |
